Stock Chart

Stock Chart

Citius Pharmaceuticals, Inc.(CTXR)

NASDAQ

$0.9

0.009(1.01%)

CTXR Company Profile

11 Commerce Drive

Cranford, NJ 07016
1.908.967.6677
http://www.citiuspharma.com
Sector: Health Technology
Industry: Pharmaceuticals: Major
Full Time Employees: 9

Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. It offers Mino-Lok, a patented solution to treat and salvage infected central venous catheters in patients with catheter related bloodstream infections and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for treatment of hemorrhoids. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.

  • Previous Close
    0.891
  • Open
    0.8925
  • Bid
    0
  • Ask
    0
  • Day's Range
    0.892 - 0.98
  • 52 week Range
    0.4 - 1.5
  • Volume
    5194426
  • Avg. Volume
    1855350
  • Market Cap
    40668210
  • Beta (5Y Monthly)
    0.8925
  • PE Ratio (TTM)
    -1.41
  • EPS (TTM)
    0
  • Earnings Date
    0.8925
  • Forward Dividend & Yield
    0.8925
  • Ex-Dividend Date
    5235495
  • 1y Target Est
    0.8925

KEEP ME INFORMED ON CTXR UPDATES

CTXR Performance

  • 5 Day
    2.4138%
  • 1 Month
    -2.0879%
  • 3 Month
    32.9851%
  • YTD
    -10.0908%
  • 1 Year
    -23.1897%

CTXR on Twitter

CTXR on iHub

CTXR News

/*
  • */